Market revenue in 2023 | USD 277.1 million |
Market revenue in 2030 | USD 257.3 million |
Growth rate | -1.1% (CAGR from 2023 to 2030) |
Largest segment | Quantitative |
Fastest growing segment | Digital |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Quantitative, Digital, End-point |
Key market players worldwide | Abbott Laboratories, Qiagen NV, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, GE Aerospace, BioMerieux SA, Roche Holding AG ADR, Fluidigm Corporation |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to real time pcr, digital pcr, and end point pcr market will help companies and investors design strategic landscapes.
Quantitative was the largest segment with a revenue share of 84.81% in 2023. Horizon Databook has segmented the Italy real time pcr, digital pcr, and end point pcr market based on quantitative, digital, end-point covering the revenue growth of each sub-segment from 2018 to 2030.
Companies specializing in RT-PCR, dPCR, and end-point solutions are actively seeking distribution agreements with local partners to expand their presence in the market. For instance, SML Genetree entered a distribution agreement with TEMA Ricerca Srl. to distribute NGS kits and Ezplex PCR.
In addition, in February 2022, Cerca Biotech entered into a distribution deal with four European partners for MammaTyper, an RT-qPCR diagnostic test for breast cancer diagnosis.
The distribution agreement covers European countries, including Germany, France, Italy, and the UK. The deal facilitates the adoption of PCR products due to the improved availability of consumables, reagents, and instruments in the market.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy real time pcr, digital pcr, and end point pcr market , including forecasts for subscribers. This country databook contains high-level insights into Italy real time pcr, digital pcr, and end point pcr market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account